Neurostimulation and Electromyographs Assessment of th TetraGraph in Healthy (Volunteers

NCT ID: NCT02630576

Last Updated: 2017-03-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-06-30

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

TetraGraph is a newly developed EMG-based (electromyograph), quantitative, battery-powered neuromuscular monitoring system intended for daily clinical use. The primary aim of this clinical investigation is to examine the applicability (ease of use, equipment need, etc.), repeatability (precision or internal consistency) and performance (signal quality, accuracy of outcome, voltage of stimulation output before and during a stimulus) and tolerability of the Tetragraph device in healthy volunteers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary endpoint will be assessment of the ability of the TetraGraph prototype to deliver neuro-stimulation, and assessment of the ability to acquire muscle action potentials and record these evoked responses on the SD-card. The study will be performed on healthy volunteers - 10 male and 10 female. Testing will be done at two separate stimulation/recording sites: ulnar nerve stimulation/abductor digiti minimi (ADM) muscle recording; and ulnar nerve stimulation/adductor pollices (AP) muscle recording. The side of testing (RIGHT vs. LEFT hand) will be determined a priori and randomly by the principal investigator, such that 10 volunteers each will be tested on the RIGHT and 10 on the LEFT hands. At each stimulating/recording site two stimulation protocols (single twitch stimulation and train-of-four stimulation) will be performed with growing current intensity (10-60 mA (milliAmps), in a 10 mA step-up fashion). Volunteers will rate the tolerability of each stimulation protocols on a visual analogue scale. EMG data will be recorded on the SD card and evaluated off-line.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Electromyography Neuromuscular Monitoring

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Men - Left Hand

5 healthy male volunteers undergoing 4 types of neuromuscular stimulation protocols on the left hand

Group Type EXPERIMENTAL

Neuromuscular stimulation

Intervention Type DEVICE

Single twitch and train-of-four stimulation protocols will be performed at the randomised side with growing current intensity

Men - Right Hand

5 healthy male volunteers undergoing 4 types of neuromuscular stimulation protocols on the right hand

Group Type EXPERIMENTAL

Neuromuscular stimulation

Intervention Type DEVICE

Single twitch and train-of-four stimulation protocols will be performed at the randomised side with growing current intensity

Women - Left Hand

5 healthy female volunteers undergoing 4 types of neuromuscular stimulation protocols on the left hand

Group Type EXPERIMENTAL

Neuromuscular stimulation

Intervention Type DEVICE

Single twitch and train-of-four stimulation protocols will be performed at the randomised side with growing current intensity

Women - Right Hand

5 healthy female volunteers undergoing 4 types of neuromuscular stimulation protocols on the right hand

Group Type EXPERIMENTAL

Neuromuscular stimulation

Intervention Type DEVICE

Single twitch and train-of-four stimulation protocols will be performed at the randomised side with growing current intensity

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Neuromuscular stimulation

Single twitch and train-of-four stimulation protocols will be performed at the randomised side with growing current intensity

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 years or older
* Volunteer is American Society of Anesthesiology (ASA) physical status I-III (Tabl
* Volunteer has provided written informed consent

Exclusion Criteria

* Presence of an underlying neuromuscular disease
* Use of medications known to interfere with neuromuscular transmission
* Presence of renal or hepatic disease
* Subject has only one upper extremity
* Subject has open sores at the skin sites needed for electrode application
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Debrecen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tamas Vegh, MD

MD, PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bela Fulesdi, MD,PhD,DSci

Role: PRINCIPAL_INVESTIGATOR

UNIVERSITY OF DEBRECEN FACULTY OF MEDICINE Department of Anesthesiology and Intensive Care Debrecen, Hungary, 4032

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Debrecen

Debrecen, , Hungary

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Hungary

References

Explore related publications, articles, or registry entries linked to this study.

Gatke MR, Viby-Mogensen J, Rosenstock C, Jensen FS, Skovgaard LT. Postoperative muscle paralysis after rocuronium: less residual block when acceleromyography is used. Acta Anaesthesiol Scand. 2002 Feb;46(2):207-13. doi: 10.1034/j.1399-6576.2002.460216.x.

Reference Type BACKGROUND
PMID: 11942873 (View on PubMed)

Cammu G, De Witte J, De Veylder J, Byttebier G, Vandeput D, Foubert L, Vandenbroucke G, Deloof T. Postoperative residual paralysis in outpatients versus inpatients. Anesth Analg. 2006 Feb;102(2):426-9. doi: 10.1213/01.ane.0000195543.61123.1f.

Reference Type BACKGROUND
PMID: 16428537 (View on PubMed)

Kim KS, Lew SH, Cho HY, Cheong MA. Residual paralysis induced by either vecuronium or rocuronium after reversal with pyridostigmine. Anesth Analg. 2002 Dec;95(6):1656-60, table of contents. doi: 10.1097/00000539-200212000-00033.

Reference Type BACKGROUND
PMID: 12456433 (View on PubMed)

Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg. 2008 Jul;107(1):130-7. doi: 10.1213/ane.0b013e31816d1268.

Reference Type BACKGROUND
PMID: 18635478 (View on PubMed)

Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg. 2010 Jul;111(1):120-8. doi: 10.1213/ANE.0b013e3181da832d. Epub 2010 May 4.

Reference Type BACKGROUND
PMID: 20442260 (View on PubMed)

Hemmerling TM, Le N. Brief review: Neuromuscular monitoring: an update for the clinician. Can J Anaesth. 2007 Jan;54(1):58-72. doi: 10.1007/BF03021901.

Reference Type BACKGROUND
PMID: 17197470 (View on PubMed)

Brull SJ, Silverman DG. Visual and tactile assessment of neuromuscular fade. Anesth Analg. 1993 Aug;77(2):352-5. doi: 10.1213/00000539-199308000-00024.

Reference Type BACKGROUND
PMID: 8394051 (View on PubMed)

Grayling M, Sweeney BP. Recovery from neuromuscular blockade: a survey of practice. Anaesthesia. 2007 Aug;62(8):806-9. doi: 10.1111/j.1365-2044.2007.05101.x.

Reference Type BACKGROUND
PMID: 17635429 (View on PubMed)

Claudius C, Viby-Mogensen J. Acceleromyography for use in scientific and clinical practice: a systematic review of the evidence. Anesthesiology. 2008 Jun;108(6):1117-40. doi: 10.1097/ALN.0b013e318173f62f.

Reference Type BACKGROUND
PMID: 18497614 (View on PubMed)

Connelly NR, Silverman DG, O'Connor TZ, Brull SJ. Subjective responses to train-of-four and double burst stimulation in awake patients. Anesth Analg. 1990 Jun;70(6):650-3. doi: 10.1213/00000539-199006000-00012.

Reference Type BACKGROUND
PMID: 2160781 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

028605-010/2014/OTIG

Identifier Type: REGISTRY

Identifier Source: secondary_id

DE RKEB/IKEB4170-2014

Identifier Type: REGISTRY

Identifier Source: secondary_id

ADBV-ABS-0214-NEAT-2H

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Thumb vs Great Toe Recovery
NCT04312256 COMPLETED NA